A detailed history of Beaumont Capital Management, LLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Beaumont Capital Management, LLC holds 28,225 shares of EPIX stock, worth $5,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,225
Holding current value
$5,645
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$0.19 - $1.93 $5,362 - $54,474
28,225 New
28,225 $5,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $8.81M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Beaumont Capital Management, LLC Portfolio

Follow Beaumont Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Capital Management, LLC with notifications on news.